Regarding liver fibrosis, no significant differences in clinical and environmental parameters were found between the two NFS score groups, except for the age and the presence of obesity, diabetes type 2, cardiovascular diseases (CVD), and the ratio of ASAT to ALAT. The gene discussed is ABCB7; the disease is obesity disorder.